182 related articles for article (PubMed ID: 15992563)
1. Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?
Richartz E; Stransky E; Batra A; Simon P; Lewczuk P; Buchkremer G; Bartels M; Schott K
J Psychiatr Res; 2005 Sep; 39(5):535-43. PubMed ID: 15992563
[TBL] [Abstract][Full Text] [Related]
2. Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production.
Pellicanò M; Bulati M; Buffa S; Barbagallo M; Di Prima A; Misiano G; Picone P; Di Carlo M; Nuzzo D; Candore G; Vasto S; Lio D; Caruso C; Colonna-Romano G
J Alzheimers Dis; 2010; 21(1):181-92. PubMed ID: 20413861
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Popp J; Bacher M; Kölsch H; Noelker C; Deuster O; Dodel R; Jessen F
J Psychiatr Res; 2009 May; 43(8):749-53. PubMed ID: 19038405
[TBL] [Abstract][Full Text] [Related]
4. Systemic immune aberrations in Alzheimer's disease patients.
Bonotis K; Krikki E; Holeva V; Aggouridaki C; Costa V; Baloyannis S
J Neuroimmunol; 2008 Jan; 193(1-2):183-7. PubMed ID: 18037502
[TBL] [Abstract][Full Text] [Related]
5. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.
Motta M; Imbesi R; Di Rosa M; Stivala F; Malaguarnera L
Immunol Lett; 2007 Nov; 114(1):46-51. PubMed ID: 17949824
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Rentzos M; Paraskevas GP; Kapaki E; Nikolaou C; Zoga M; Rombos A; Tsoutsou A; Vassilopoulos D D
J Neurol Sci; 2006 Nov; 249(2):110-4. PubMed ID: 16843497
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
[TBL] [Abstract][Full Text] [Related]
8. [Concentrations of pro-inflammatory cytokines IFN-gamma, IL-6, IL-12 and IL-15 in serum and cerebrospinal fluid in patients with neuroborreliosis undergoing antibiotic treatment].
Pancewicz SA; Kondrusik M; Zajkowska J; Grygorczuk S
Pol Merkur Lekarski; 2007 Apr; 22(130):275-9. PubMed ID: 17684925
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A
Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients.
Speciale L; Calabrese E; Saresella M; Tinelli C; Mariani C; Sanvito L; Longhi R; Ferrante P
Neurobiol Aging; 2007 Aug; 28(8):1163-9. PubMed ID: 16814429
[TBL] [Abstract][Full Text] [Related]
11. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
12. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.
Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
Immunol Lett; 2008 May; 117(2):198-202. PubMed ID: 18367253
[TBL] [Abstract][Full Text] [Related]
13. Altered lymphocyte distribution in Alzheimer's disease.
Richartz-Salzburger E; Batra A; Stransky E; Laske C; Köhler N; Bartels M; Buchkremer G; Schott K
J Psychiatr Res; 2007; 41(1-2):174-8. PubMed ID: 16516234
[TBL] [Abstract][Full Text] [Related]
14. [Serum levels of macrophage colony stimulating factor in the patients with Alzheimer's disease].
Kong QL; Zhang JM; Zhang ZX; Ge PJ; Xu YJ; Mi RS; Zhao YH; Sui YP; He W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):298-301. PubMed ID: 12905639
[TBL] [Abstract][Full Text] [Related]
15. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia.
Di Rosa M; Dell'Ombra N; Zambito AM; Malaguarnera M; Nicoletti F; Malaguarnera L
Eur J Neurosci; 2006 May; 23(10):2648-56. PubMed ID: 16817867
[TBL] [Abstract][Full Text] [Related]
16. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B
Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
18. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines.
Reale M; Iarlori C; Gambi F; Feliciani C; Salone A; Toma L; DeLuca G; Salvatore M; Conti P; Gambi D
J Neuroimmunol; 2004 Mar; 148(1-2):162-71. PubMed ID: 14975597
[TBL] [Abstract][Full Text] [Related]
19. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
[TBL] [Abstract][Full Text] [Related]
20. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.
Zuliani G; Ranzini M; Guerra G; Rossi L; Munari MR; Zurlo A; Volpato S; Atti AR; Blè A; Fellin R
J Psychiatr Res; 2007 Oct; 41(8):686-93. PubMed ID: 16600299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
